The Use of Progesterone to Reduce Preterm Birth

NACompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

January 31, 2010

Study Completion Date

June 30, 2010

Conditions
Preterm Birth
Interventions
DRUG

Progesterone (OHP17)

100mg of OHP17 or comparable amount of placebo administered by IM injection weekly until either 34 weeks' gestation or delivery has been achieved, whichever occurs first.

DRUG

Placebo

2cc of placebo liquid formulated by pharmacy personnel at the University of Mississippi Medical Center injected IM weekly until 34 weeks' gestation has been reached or delivery, whichever occurs first.

Trial Locations (1)

39216

Winfred L Wiser Hospital for Women and Infants at the University of Mississippi Medical Center, Jackson

All Listed Sponsors
lead

University of Mississippi Medical Center

OTHER

NCT00830765 - The Use of Progesterone to Reduce Preterm Birth | Biotech Hunter | Biotech Hunter